FDA: Chantix may carry heart risks

December 13, 2012 1:47:27 PM PST
The Federal Drug Administration is warning that the stop-smoking drug Chantix may carry heart risks.

The FDA says as a result, doctors should weigh the risks of the drug against its benefits.

A major review of the drug found slightly higher rates of serious cardiovascular events, including non-fatal heart attacks, non-fatal stroke and cardiovascular-related death.

Experts are quick to point out that the increased risk was not statistically significant. They are asking that smokers talk to their doctors before taking the drug.

Load Comments